Report #2877365

Received Dec 11, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (2)

Injection site painMalaise

Symptom narrative

injection site soreness; Feeling sick; This non-serious case was reported by a physician via sales rep and described the occurrence of injection site pain in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: injection site soreness) and feeling unwell (Verbatim: Feeling sick). The outcome of the injection site pain and feeling unwell were resolved. The reporter considered the injection site pain and feeling unwell to be related to Shingrix. The company considered the injection site pain and feeling unwell to be related to Shingrix. Additional Information: GSK receipt date 02-DEC-2025 The batch number was not provided, and we are unable to contact the reporter.